First At-Home Coronavirus Test Approved by FDA

First At-Home Coronavirus Test Approved by FDA

The first at-home COVID-19 test will soon be available for $50.

The FDA announced on November 17 that it had approved the first diagnostic at-home self-administered coronavirus test, according to NPR.

The Lucira COVID-19 All-In-One Test Kit will be sold for $50. The molecular single-use test works by being swirled in a swabbed sample and placed in a hand-held test unit. Results are available in 30 minutes, with the unit’s display lighting up to inform users of a positive or negative test result.

“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” said FDA Commissioner Stephen Hahn.

The test will be available via prescription to people who are 14-years-old and older. Younger patients must receive the test from a health care professional.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Product Showcase

  • SlateSafety BAND V2

    SlateSafety BAND V2

    SlateSafety's BAND V2 is the most rugged, easy-to-use connected safety wearable to help keep your workforce safe and help prevent heat stress. Worn on the upper arm, this smart PPE device works in tandem with the SlateSafety V2 system and the optional BEACON V2 environmental monitor. It includes comprehensive, enterprise-grade software that provides configurable alert thresholds, real-time alerts, data, and insights into your safety program's performance all while ensuring your data is secure and protected. Try it free for 30 days. 3

Featured

Webinars